1Ekbom KA. Restless legs syndrome. Neurol, 1960,10 :868-873.
2Strang RR. The symptom of restless legs. Med J Aust, 1967,1 :1211-1213.
3Rothdach AJ, Winkelmann J. Trenkwalder C, et al.Prevalence of restless legs syndrome in an elderly general population: the MEMO-study. Neurol, 1960,Suppl 2 :A287-288.
4Rothdach AJ, Trenkwalder C, Haberstock J, et al.Prevalence and risk factors of RLS in an elderly population: the MEMO study. Neurol, 2000, 54:1060-1068.
5Clark MM. Restless legs syndrome. Am Board Fam Pract, 2001,14:368-374.
6Mizuno S, Miyaoka T, Inagakl T, et al. Prevalence of restless legs syndrome in non-lnstitutionallzed Japanese elderly. Psychiat Clin Neuroscien, 2005, 59:461-465.
7Collado-Seidel V, Winkelmann J, Trenkwalder C.Aetiology and treatment of restless legs syndrome.CNS Drugs, 1999, 12: 9-20.
8Garcia-Borreguero D, Odin P, Schwarz C. Restless legs syndrome: An overview of the current understanding and management. Act Neurol Scandinavica, 2004,109 :303.
9Berg K, von-Eckardstein A, Trenkwalder C, et al. Iron metabolism and the risk of RLS in an elderly general population-the MEMO study. J Neurol, 2002:1195-1199.
10Trenkwalder C, Stiasny K, Pollmacher TH, et al.L-dopa therapy of uremic and idiopathic restless legs syndrome, a double-blind, crossover trial. Sleep,1995,18..681-688.
